Insiders · HLVX

Gary Dubin

Director at HilleVax, Inc. (HLVX)

Gary Dubin has filed 2 insider reports with the SEC since June 2025, as director at HilleVax, Inc. (HLVX). The latest filing, on September 17, 2025, reports tender of shares in a change of control at HilleVax, Inc. (HLVX).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Gary Dubin is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
HilleVax, Inc. logo
HLVX
HilleVax, Inc.
Director0Sep 17, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Gary Dubin with

Other insiders at the same companies

Questions about Gary Dubin

What is Gary Dubin's role at HilleVax, Inc.?
Gary Dubin reports to the SEC as director at HilleVax, Inc. (HLVX), according to the latest filing on September 17, 2025.
Has Gary Dubin bought or sold stock recently?
No open-market purchases or sales by Gary Dubin are on file. The filings report tender of shares in a change of control and grant or award.
How do I get alerts when Gary Dubin files?
Follow Gary Dubin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Gary Dubin (SEC CIK 0001923607). Totals count each trade once, skipping amendments whose original is on file, from Jun 25, 2025 on. View on SEC EDGAR · Get this as JSON